General Comments / Chat, page-6144

  1. 3,400 Posts.
    lightbulb Created with Sketch. 3216
    What is the focus of Pillar 3. Basically, global domination of the m6A RNA eraser space. As Zantrene is cytotoxic is ideal for deadly cancers but not so good for diabetes patients.

    I believe Type 2 diabetes (T2D) is a strong target as part of this program.

    T2D Mechanism of Action: Nutrients | Free Full-Text | Fat Mass and Obesity Associated (FTO) Gene and Hepatic Glucose and Lipid Metabolism (mdpi.com)

    https://hotcopper.com.au/data/attachments/4842/4842705-e1a942ea66103a17f28ea69093529dfa.jpg

    FTO Overexpression: Fat mass and obesity-associated gene expression and disease severity in type 2 diabetes mellitus - ScienceDirect

    https://hotcopper.com.au/data/attachments/4842/4842700-b00f813232677496ed5b89631ead1335.jpg

    Zantrene / Bistantrene (CS1) Working as a potential T2D solution: Cells | Free Full-Text | Glucose Regulates m6A Methylation of RNA in Pancreatic Islets | HTML (mdpi.com)

    Commercial opportunity (TAM): Type 2 Diabetes Market Size, Share, Growth | Report 2022-2030 (precedenceresearch.com)

    https://hotcopper.com.au/data/attachments/4842/4842718-b68735da72d466c68dd9c77bb2a648e7.jpg





 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
$1.22
Change
-0.065(5.06%)
Mkt cap ! $211.9M
Open High Low Value Volume
$1.29 $1.29 $1.21 $205.4K 165.5K

Buyers (Bids)

No. Vol. Price($)
1 788 $1.22
 

Sellers (Offers)

Price($) Vol. No.
$1.23 42 1
View Market Depth
Last trade - 16.10pm 24/06/2025 (20 minute delay) ?
RAC (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.